Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Recruiting 2Completed 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 4Ovarian Neoplasms 3Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 3Colorectal Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Small Cell Lung Carcinoma 1Skin Neoplasms 1Select Advanced Solid Tumors 1SCLC, Extensive Stage 1SCLC 1Retinoblastoma 1Retinal Neoplasms 1Recurrence 1Radiation Therapy 1Prostatic Neoplasms 1

Interventions

Cisplatin 10pembrolizumab 8Carboplatin 8durvalumab 5Pemetrexed 5Paclitaxel 51-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 5osimertinib 4Specimen Handling 4Magnetic Resonance Spectroscopy 4Taxes 3Gemcitabine 3Bevacizumab 3cabozantinib 2atezolizumab 2Sunitinib 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Platinum 2Nivolumab 2Immunoglobulin G 2Docetaxel 2Disulfides 2CP protocol 2Biopsy 21,2-diaminocyclohexaneplatinum II citrate 2tremelimumab 1relatlimab 1peposertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Carcinoma × Drug Therapy × Clear all
NCT02994069 2025-10-14

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

University of Kentucky

Phase 2 Active not recruiting
80 enrolled 11 charts
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡